跳至主要内容
临床试验/ITMCTR2200006668
ITMCTR2200006668尚未招募2 期

Exploring the Optimal Diagnosis and Treatment Strategy of Traditional Chinese Medicine Preparation Sangqi Qingxuan Ointment For Prevention and Treatment of Prehypertension and Grade 1 Hypertension:Based on the Regulation of Autonomic Nerve Function

China-Japan Friendship Hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
2 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

性别
All

入选标准

  • 1. Understand the process of this trial, participate voluntarily and sign the informed consent
  • 2. Meet the diagnostic criteria for primary hypertension grade 1 or prehypertension
  • 3. In line with the TCM dialectical diagnosis of Yin deficiency of liver and kidney and/or hyperactivity of liver Yang and mutual junction of phlegm and blood stasis
  • 4. No combined use of any western antihypertensive drugs
  • 5. Age between 18 and 70

排除标准

  • 1. Those who cannot cooperate
  • 2. Patients with secondary hypertension
  • 3. Abnormal liver function, ALT, AST is more than 2 times the upper limit of normal
  • 4. Kidney damage, blood creatinine greater than 133mmol/L
  • 5. Patients with severe chronic gastrointestinal diseases
  • 6. Active myocarditis or pericarditis
  • 7. Unstable angina within 2 weeks
  • 8. Planned cardiac surgery
  • 9. Patients with significant hematologic disorders
  • 10. Allergic to the test drug
  • 11. Psychiatric disorders, drug or other substance abuse
  • 12. Stressful situations such as surgery and severe trauma
  • 13. Lactating women and women who are pregnant or preparing for pregnancy in the near future

研究者

发起方
China-Japan Friendship Hospital

相似试验